Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Tagraxofusp in combination with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma shows encouraging preliminary efficacy with a manageable safety profile

Dana-Farber Cancer Institute, Boston, MA
City of Hope, Duarte, CA
Oregon Health and Science University, Portland, OR
Dana-Farber Cancer Institute, Boston, MA
Menarini Group, New York, NY
Haematologica Early view Oct 3, 2024 https://doi.org/10.3324/haematol.2024.285380

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2024.285380
Pubmed
39363849
 
Published
2024-10-03
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2024 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
407
PDF Downloads
179

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2024 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online